Memorial Sloan Kettering Cancer Center
Cancer immunologist to present AACR-Irving Weinstein Foundation Distinguished Lectureship
Andrea Schietinger, PhD, will present the 19th AACR-Irving Weinstein Foundation Distinguished Lectureship during the American Association for Cancer Research Annual Meeting, which will be held April 14-19 in Florida.
Patients fail to receive 1 in 8 oral anticancer drug prescriptions
An increasing number of oral anticancer drugs have been granted FDA approval and introduced into clinical practice.
CAR-T effective after early relapse for high-risk multiple myeloma
NEW ORLEANS — Idecabtagene vicleucel induced initial complete remission in nearly half of patients with multiple myeloma who had early relapse after front-line therapy, results of a cohort analysis of the phase 2 KarMMa-2 trial showed.
Non-European HSCT recipients undergo more complex procedures with fewer resources
Hematopoietic stem cell transplant recipients of non-European ancestry had a significantly higher likelihood of receiving allogeneic grafts from HLA-mismatched donors than individuals of European ancestry, study results showed.
‘Big culture shift’ required to improve cancer care for LGBTQ+ individuals
Individuals who identify as LGBTQ+ continue to face barriers when trying to access high-quality and inclusive cancer care, according to panelists at the annual National Comprehensive Cancer Network Patient Advocacy Summit.
Guideline addresses use of integrative therapies for cancer-related pain management
A new clinical practice guideline jointly published by ASCO and Society for Integrative Oncology addresses the potential role of integrative pain management techniques in management of cancer-related pain in adults.
CAR-T destined for earlier lines of therapy in blood cancers, experts say
Despite data on the approach still being accumulated, a panel of experts at Chemotherapy Foundation Symposium predicted that chimeric antigen receptor T cells will become front-line therapy for multiple hematologic malignancies.
Early treatment of COVID-19 crucial for patients with cancer
More than 2 years after the COVID-19 pandemic began, new treatments, vaccines and preventive measures have improved safety and disease outcomes for patients with cancer, according to a speaker at Chemotherapy Foundation Symposium.
Guideline provides recommendations for integrative approaches to manage cancer pain
Several forms of integrative medicine can effectively relieve pain caused by cancer and its treatments, according to study results.
Proton partial breast radiotherapy appears effective, safe for early breast cancer
Proton therapy for partial breast irradiation provided cancer control in 100% of cases of early-stage ER-positive breast cancer, according to 3-year results from a prospective, multicenter phase 2 trial.